At BIO International Convention 2026 in San Diego, BioSpectrum Asia spoke with Dr. Christoffer Norn, Co-founder and CEO ...
When the BIO International Convention opens in San Diego on 22 June, the Italian National Pavilion will arrive carrying ...
Sonire Therapeutics has received approximately $13 million in non-dilutive funding through Japan’s NEDO Deep-Tech ...
Insilico Medicine has completed first-in-human dosing in the Phase I clinical study of ISM8969, an AI-driven small-molec...
The Tang Prize Foundation has awarded the 2026 Tang Prize in Biopharmaceutical Science to three pioneers of cellular imm...
MindWalk Holdings Corp. is positioning biological data infrastructure as a key bottleneck in AI-enabled drug discovery, ...
Niowave and Ratio Therapeutics have signed a supply agreement for Actinium-225, strengthening Ratio’s access to a ...
When the global biotech community converges on the San Diego Convention Center this June, it does so in a market still f...
Hillhurst Bio has dosed the first subject in its Phase 2a clinical trial evaluating HBI-002 for the treatment of Parkins...
Neurocrine Biosciences has presented the first retrospective case series of CRENESSITY in patients with classic congenit...
Minghui Pharmaceutical has presented complete Phase I/II clinical data for MHB018A, a subcutaneous anti-IGF-1R antibody ...
Johnson & Johnson has announced an investment of more than $1 billion in Jacksonville, Florida to strengthen its Vis...
Lundbeck has presented preliminary Phase II Part A data for asedebart, an investigational anti-adrenocorticotropic hormo...
SCbio will spotlight South Carolina’s expanding life sciences sector at BIO International Convention 2026 in San D...
In a landmark achievement in biological imaging, researchers at Biohub and the University of California, Berkeley today ...
Genentech has received U.S. FDA acceptance and Priority Review for its New Drug Application for giredestrant as an adjuv...
Nuvalent has received U.S. FDA acceptance and Priority Review for its New Drug Application for neladalkib in tyrosine ki...
MEDIPOST has secured FDA agreement to conduct a single pivotal Phase III study for CARTISTEM in the US, marking an impor...
Pfizer has received US FDA approval for an expanded indication of Hympavzi for hemophilia A or B, broadening its use to ...
Shionogi has received US FDA approval for XOCOVA, or ensitrelvir, as an oral post-exposure prophylaxis option for COVID-...
Eli Lilly has reported detailed Phase III results from three ACHIEVE trials evaluating Foundayo, or orforglipron, an ora...
US-based Phenomenex Inc., a Danaher Company and a global leader in the research and manufacture of advanced technologies...
Otsuka has reported positive interim Phase III VISIONARY data showing that VOYXACT preserved kidney function over 12 mon...
SGS has acquired CMIC, INC., a specialised bioanalytical testing services provider based in Chicago, Illinois, strengthe...
Johnson & Johnson has received US FDA approval for a supplemental Biologics License Application to include evidence ...
